ZIM Laboratories Limited (BOM:541400)
India · Delayed Price · Currency is INR 117.60
-2.40 (-2.00%)
At close: Jul 27, 2026
ZIM Laboratories Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 3,744 | 3,744 | 3,790 | 3,675 | 3,986 | 3,335 |
Revenue Growth | -1.22% | -1.22% | 3.13% | -7.80% | 19.52% | 8.51% |
Gross Profit Gross Profit Growth | 1,974 | 1,974 | 2,032 | 1,860 | 1,914 | 1,665 |
Operating Income Operating Income Growth | 102.99 | 102.99 | 244.7 | 256.66 | 352.59 | 250.31 |
Net Income Net Income Growth | 58.38 | 58.38 | 121.65 | 172.46 | 244.35 | 145.5 |
Earnings Per Share EPS Growth | 1.19 | 1.19 | 2.50 | 3.54 | 5.01 | 2.99 |
EPS Growth | -52.34% | -52.34% | -29.46% | -29.35% | 67.77% | 99.08% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 594.43 | 594.43 | 665.69 | 804.64 | 603.38 | 632.97 |
Outside India Outside India Growth | 3,150 | 3,150 | 3,125 | 2,870 | 3,382 | 2,701 |
Total Total Growth | 3,744 | 3,744 | 3,790 | 3,674 | 3,985 | 3,334 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 402.52 | 402.52 | 20.37 | 98.84 | 64.21 | 34.2 |
Total Debt Total Debt Growth | 1,266 | 1,266 | 1,178 | 1,118 | 621.58 | 534.37 |
Net Cash (Debt) Net Cash Growth | -863.07 | -863.07 | -1,158 | -1,019 | -557.38 | -500.17 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -17.62 | -17.62 | -23.76 | -20.91 | -11.44 | -10.26 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 495.34 | 495.34 | 411.55 | 162.78 | 381.68 | 492.06 |
Capital Expenditures CapEx Growth | -443.87 | -443.87 | -407.98 | -739.23 | -366.68 | -152.25 |
Free Cash Flow Free Cash Flow Growth | 51.48 | 51.48 | 3.57 | -576.45 | 15 | 339.81 |
Free Cash Flow Growth | 1342.31% | 1342.31% | - | - | -95.58% | 33.92% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 52.74% | 52.74% | 53.62% | 50.60% | 48.01% | 49.93% |
Operating Margin | 2.75% | 2.75% | 6.46% | 6.98% | 8.85% | 7.51% |
Pretax Margin | 2.19% | 2.19% | 4.75% | 6.43% | 8.87% | 6.31% |
Profit Margin | 1.56% | 1.56% | 3.21% | 4.69% | 6.13% | 4.36% |
FCF Margin | 1.38% | 1.38% | 0.09% | -15.68% | 0.38% | 10.19% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 98.82 | 54.87 | 32.12 | 26.98 | 14.44 | 17.84 |
P/FCF Ratio | 122.34 | 62.22 | 1094.93 | - | 235.14 | 7.64 |
PS Ratio | 1.68 | 0.86 | 1.03 | 1.27 | 0.89 | 0.78 |